HEALTH
Coronavirus: NAFDAC Approves Chloroquine for Clinical Trials
The National Agency for Food and Drug Administration and Control ( NAFDAC ) has approved the production of chloroquine for clinical trials in the search for a cure for COVID19.
The National Agency for Food and Drug Administration and Control ( NAFDAC ) has approved the production of chloroquine for clinical trials in the search for a cure for COVID19.

This was made known by the Director-General of the agency, Mojisola Adeyeye, on Friday.
The DG said that NAFDAC is not approving Chloroquine for the treatment of COVID-19 but for clinical trials to find treatment for the virus.
“NAFDAC is not approving Chloroquine as a product that can be used for Coronavirus because there is no submission to us for registration but because it is under clinical trials, NAFDAC approves medicines meant for clinical trials.

Therefore the medicine is being approved just for the clinical trials,” Adeyeye said. She, therefore, called on experts and researchers that are interested in doing a clinical trial on Chloroquine to approach approved outlets.
“Right now, we have asked one company to make a batch of Chloroquine for the purpose of the clinical trial,” Adeyeye added.
For publication of your news content, articles, videos or any other news worthy materials, please send to newsleverage1@gmail.com. For more enquiry, please call +234-901-067-1763 or whatsapp +234-901-067-1763. To place an advert, please call 09010671763
-
NATIONAL NEWS1 week agoADC Expels Don Norman Obinna, Nafiu Bala, Other Erring Members
-
Articles2 weeks agoGeneral Oluyede and the Prodigal Sons Who Return Only to Kill – Mahmud
-
Articles6 days agoGuess Who’s Coming – Abdul Mahmud
-
METRO2 weeks agoAkpabio’s Daughter Named Akwa Ibom Director of City Boy Movement
-
METRO4 weeks agoApostle Chibuzor Pledges Lifelong Support for Any Lady Who Agrees to Marry Groom
